Related Experiment Video
Updated: Aug 16, 2026
14:40
Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Summary
AH8165, a novel non-depolarizing muscle relaxant, is effective for Cesarean sections. It acts rapidly and shows minimal placental transfer, making it suitable for obstetric anesthesia.
Area of Science:
- Anesthesiology
- Obstetrics
- Pharmacology
Background:
- Cesarean sections require safe and effective anesthetic agents.
- Non-depolarizing muscle relaxants are commonly used in surgical anesthesia.
- Evaluating new agents for obstetric use is crucial for maternal and fetal safety.
Purpose of the Study:
- To evaluate the efficacy and safety of AH8165 in Cesarean sections.
- To assess the onset and duration of action of AH8165.
- To determine the extent of placental transfer of AH8165.
Main Methods:
- Clinical study involving patients undergoing Cesarean section.
- Administration of AH8165 as a neuromuscular blocking agent.
- Monitoring of anesthetic and neuromuscular effects, and assessment of drug transfer.
Main Results:
- AH8165 demonstrated rapid onset of neuromuscular blockade.
- No significant transfer of AH8165 across the placenta was observed.
- The drug proved effective and safe for use in obstetric anesthesia.
Conclusions:
- AH8165 is a suitable non-depolarizing relaxant for Cesarean delivery.
- Its rapid action and low placental transfer profile are advantageous.
- AH8165 offers a valuable option for obstetric anesthesia practice.
